Verdeso

Product manufactured by Aqua Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA021978 2006-09-19 Topical RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Verdeso® (desonide) Foam, 0.05% Is Indicated For The Treatment Of Mild To Moderate Atopic Dermatitis In Patients 3 Months Of Age And Older. Patients Should Be Instructed To Use Verdeso Foam For The Minimum Amount Of Time Necessary To Achieve The Desired Results Because Of The Potential For Verdeso Foam To Suppress The Hypothalamic-Pituitary-Adrenal (hpa) Axis. Treatment Should Not Exceed 4 Consecutive Weeks. Verdeso Foam Is A Corticosteroid Indicated For The Topical Treatment Of Mild To Moderate Atopic Dermatitis In Patients 3 Months Of Age And Older. (1)

All Formulated Excipients (8 Total)

Name Structure Kind Function Status
1. Cetyl Alcohol CETYL ALCOHOL Molecular
2. Cyclomethicone CYCLOMETHICONE Molecular
3. Isopropyl Myristate ISOPROPYL MYRISTATE Molecular
4. Light Mineral Oil LIGHT MINERAL OIL Unresolved
5. Polyoxyl 20 Cetostearyl Ether POLYOXYL 20 CETOSTEARYL ETHER Unresolved
6. Propylene Glycol PROPYLENE GLYCOL Molecular MISC-Miscellaneous FS-Substances permitted as optional ingredient in a standardized food.
7. Water WATER Molecular
8. Sorbitan Monolaurate SORBITAN MONOLAURATE Molecular

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Desonide DESONIDE ZINC4212851

Comments